Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
August 2026
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Jun 20, 2024
Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe
GlobeNewswire
Read ↗
Jun 17, 2024
Femasys At Inflection Point And Undervalued, CEO Says
Benzinga
Read ↗
Jun 12, 2024
Health Tech: Kathy Lee-Sepsick of Femasys On How Their Technology Can Make An Important Impact
Authority Magazine / Medium
Read ↗
Jun 4, 2024
Femasys founder Kathy Lee-Sepsick on entrepreneurship and the need for innovation in women’s health
FemTech World
Read ↗
May 17, 2024
Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative
GlobeNewswire
Read ↗
May 16, 2024
Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council
GlobeNewswire
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.